APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cancer Diagnostics Service

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cancer Diagnostics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026196 pages

Choose your research edition.

Industry ResearchCancer Diagnostics Service Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Diagnostics Service Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Cancer Diagnostics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Diagnostics Service Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Diagnostics Service Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Cancer Diagnostics Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Cancer Diagnostics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cancer Diagnostics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cancer Diagnostics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cancer Diagnostics Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cancer Diagnostics Service include Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, Abbott, QIAGEN, Siemens Healthcare GmbH and Thermo Fisher Scientific, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Cancer Diagnostics Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cancer Diagnostics Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cancer Diagnostics Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cancer Diagnostics Service market size, projected growth trends, production technologies, key applications, and end-use industries.

Cancer Diagnostics Service Segment by Company

Illumina

BGI Genomics Co.,Ltd.

Agilent Technologies

Macrogen

Pacific Biosciences

Abbott

QIAGEN

Siemens Healthcare GmbH

Thermo Fisher Scientific, Inc.

Applied DNA Sciences

Cancer Diagnostics Service Segment by Type

Breast Cancer

Blood Cancer

Lung Cancer

Colorectal Cancer

Ovarian Cancer

Others

Cancer Diagnostics Service Segment by Application

Hospitals

Ambulatory Surgical Centers

Diagnostic Laboratories

Others

Cancer Diagnostics Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Diagnostics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Diagnostics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Diagnostics Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cancer Diagnostics Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cancer Diagnostics Service industry.

Chapter 3: Detailed analysis of Cancer Diagnostics Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Diagnostics Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cancer Diagnostics Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Breast Cancer Table 3. Key Players of Blood Cancer Table 4. Key Players of Lung Cancer Table 3. Key Players of Colorectal Cancer Table 4. Key Players of Ovarian Cancer Table 5. Key Players of Others Table 6. Global Cancer Diagnostics Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Hospitals Table 8. Key Players of Ambulatory Surgical Centers Table 9. Key Players of Diagnostic Laboratories Table 10. Key Players of Others Table 11. Global Cancer Diagnostics Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Cancer Diagnostics Service Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Cancer Diagnostics Service Market Share by Region (2021-2026) Table 14. Global Cancer Diagnostics Service Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Cancer Diagnostics Service Market Share by Region (2027-2032) Table 16. Cancer Diagnostics Service Industry Trends Table 17. Cancer Diagnostics Service Industry Drivers Table 18. Cancer Diagnostics Service Industry Opportunities and Challenges Table 19. Cancer Diagnostics Service Industry Restraints Table 20. Global Cancer Diagnostics Service Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Cancer Diagnostics Service Revenue Market Share by Company (2021-2026) Table 22. Global Cancer Diagnostics Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Cancer Diagnostics Service Key Company Head Office and Area Served Table 24. Global Cancer Diagnostics Service Company, Product Type & Application Table 25. Global Cancer Diagnostics Service Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Cancer Diagnostics Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Cancer Diagnostics Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Cancer Diagnostics Service Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Cancer Diagnostics Service Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Cancer Diagnostics Service Revenue Market Share by Type (2021-2026) Table 32. Global Cancer Diagnostics Service Revenue Market Share by Type (2027-2032) Table 33. Global Cancer Diagnostics Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Cancer Diagnostics Service Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Cancer Diagnostics Service Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Cancer Diagnostics Service Revenue Market Share by Application (2021-2026) Table 37. Global Cancer Diagnostics Service Revenue Market Share by Application (2027-2032) Table 38. Illumina Company Information Table 39. Illumina Business Overview Table 40. Illumina Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Illumina Cancer Diagnostics Service Product Portfolio Table 42. Illumina Recent Development Table 43. BGI Genomics Co.,Ltd. Company Information Table 44. BGI Genomics Co.,Ltd. Business Overview Table 45. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product Portfolio Table 47. BGI Genomics Co.,Ltd. Recent Development Table 48. Agilent Technologies Company Information Table 49. Agilent Technologies Business Overview Table 50. Agilent Technologies Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Agilent Technologies Cancer Diagnostics Service Product Portfolio Table 52. Agilent Technologies Recent Development Table 53. Macrogen Company Information Table 54. Macrogen Business Overview Table 55. Macrogen Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Macrogen Cancer Diagnostics Service Product Portfolio Table 57. Macrogen Recent Development Table 58. Pacific Biosciences Company Information Table 59. Pacific Biosciences Business Overview Table 60. Pacific Biosciences Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Pacific Biosciences Cancer Diagnostics Service Product Portfolio Table 62. Pacific Biosciences Recent Development Table 63. Abbott Company Information Table 64. Abbott Business Overview Table 65. Abbott Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Abbott Cancer Diagnostics Service Product Portfolio Table 67. Abbott Recent Development Table 68. QIAGEN Company Information Table 69. QIAGEN Business Overview Table 70. QIAGEN Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. QIAGEN Cancer Diagnostics Service Product Portfolio Table 72. QIAGEN Recent Development Table 73. Siemens Healthcare GmbH Company Information Table 74. Siemens Healthcare GmbH Business Overview Table 75. Siemens Healthcare GmbH Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Siemens Healthcare GmbH Cancer Diagnostics Service Product Portfolio Table 77. Siemens Healthcare GmbH Recent Development Table 78. Thermo Fisher Scientific, Inc. Company Information Table 79. Thermo Fisher Scientific, Inc. Business Overview Table 80. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product Portfolio Table 82. Thermo Fisher Scientific, Inc. Recent Development Table 83. Applied DNA Sciences Company Information Table 84. Applied DNA Sciences Business Overview Table 85. Applied DNA Sciences Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Applied DNA Sciences Cancer Diagnostics Service Product Portfolio Table 87. Applied DNA Sciences Recent Development Table 88. North America Cancer Diagnostics Service Market Size by Type (2021-2026) & (US$ Million) Table 89. North America Cancer Diagnostics Service Market Size by Type (2027-2032) & (US$ Million) Table 90. North America Cancer Diagnostics Service Market Size by Application (2021-2026) & (US$ Million) Table 91. North America Cancer Diagnostics Service Market Size by Application (2027-2032) & (US$ Million) Table 92. North America Cancer Diagnostics Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. North America Cancer Diagnostics Service Market Size by Country (2021-2026) Table 94. North America Cancer Diagnostics Service Market Size by Country (2027-2032) Table 95. Europe Cancer Diagnostics Service Market Size by Type (2021-2026) & (US$ Million) Table 96. Europe Cancer Diagnostics Service Market Size by Type (2027-2032) & (US$ Million) Table 97. Europe Cancer Diagnostics Service Market Size by Application (2021-2026) & (US$ Million) Table 98. Europe Cancer Diagnostics Service Market Size by Application (2027-2032) & (US$ Million) Table 99. Europe Cancer Diagnostics Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Europe Cancer Diagnostics Service Market Size by Country (2021-2026) Table 101. Europe Cancer Diagnostics Service Market Size by Country (2027-2032) Table 102. China Cancer Diagnostics Service Market Size by Type (2021-2026) & (US$ Million) Table 103. China Cancer Diagnostics Service Market Size by Type (2027-2032) & (US$ Million) Table 104. China Cancer Diagnostics Service Market Size by Application (2021-2026) & (US$ Million) Table 105. China Cancer Diagnostics Service Market Size by Application (2027-2032) & (US$ Million) Table 106. Asia Cancer Diagnostics Service Market Size by Type (2021-2026) & (US$ Million) Table 107. Asia Cancer Diagnostics Service Market Size by Type (2027-2032) & (US$ Million) Table 108. Asia Cancer Diagnostics Service Market Size by Application (2021-2026) & (US$ Million) Table 109. Asia Cancer Diagnostics Service Market Size by Application (2027-2032) & (US$ Million) Table 110. Asia Cancer Diagnostics Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Asia Cancer Diagnostics Service Market Size by Country (2021-2026) Table 112. Asia Cancer Diagnostics Service Market Size by Country (2027-2032) Table 113. South America, Middle East & Africa Cancer Diagnostics Service Market Size by Type (2021-2026) & (US$ Million) Table 114. South America, Middle East & Africa Cancer Diagnostics Service Market Size by Type (2027-2032) & (US$ Million) Table 115. South America, Middle East & Africa Cancer Diagnostics Service Market Size by Application (2021-2026) & (US$ Million) Table 116. South America, Middle East & Africa Cancer Diagnostics Service Market Size by Application (2027-2032) & (US$ Million) Table 117. South America, Middle East & Africa Cancer Diagnostics Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. South America, Middle East & Africa Cancer Diagnostics Service Market Size by Country (2021-2026) Table 119. South America, Middle East & Africa Cancer Diagnostics Service Market Size by Country (2027-2032) Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Cancer Diagnostics Service Product Image Figure 2. Global Cancer Diagnostics Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Cancer Diagnostics Service Market Share by Type: 2025 VS 2032 Figure 4. Breast Cancer Image Figure 5. Blood Cancer Image Figure 6. Lung Cancer Image Figure 7. Colorectal Cancer Image Figure 8. Ovarian Cancer Image Figure 9. Others Image Figure 10. Global Cancer Diagnostics Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Cancer Diagnostics Service Market Share by Application: 2025 VS 2032 Figure 12. Hospitals Image Figure 13. Ambulatory Surgical Centers Image Figure 14. Diagnostic Laboratories Image Figure 15. Others Image Figure 16. Global Cancer Diagnostics Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 18. Global Cancer Diagnostics Service Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Cancer Diagnostics Service Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Cancer Diagnostics Service Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Cancer Diagnostics Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Cancer Diagnostics Service Revenue Market Share by Type (2021-2032) Figure 25. Global Cancer Diagnostics Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Cancer Diagnostics Service Revenue Market Share by Application (2021-2032) Figure 27. North America Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 28. North America Cancer Diagnostics Service Market Share by Type (2021-2032) Figure 29. North America Cancer Diagnostics Service Market Share by Application (2021-2032) Figure 30. North America Cancer Diagnostics Service Market Share by Country (2021-2032) Figure 31. United States Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 32. Canada Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 34. Europe Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 35. Europe Cancer Diagnostics Service Market Share by Type (2021-2032) Figure 36. Europe Cancer Diagnostics Service Market Share by Application (2021-2032) Figure 37. Europe Cancer Diagnostics Service Market Share by Country (2021-2032) Figure 38. Germany Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 39. France Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 41. Italy Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 42. Russia Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 44. China Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 45. China Cancer Diagnostics Service Market Share by Type (2021-2032) Figure 46. China Cancer Diagnostics Service Market Share by Application (2021-2032) Figure 47. Asia Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 48. Asia Cancer Diagnostics Service Market Share by Type (2021-2032) Figure 49. Asia Cancer Diagnostics Service Market Share by Application (2021-2032) Figure 50. Asia Cancer Diagnostics Service Market Share by Country (2021-2032) Figure 51. Japan Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 55. India Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 56. Australia Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Cancer Diagnostics Service Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Cancer Diagnostics Service Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Cancer Diagnostics Service Market Share by Country (2021-2032) Figure 61. Brazil Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 66. UAE Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 68. Chile Cancer Diagnostics Service Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Breast Cancer
  • Blood Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Ovarian Cancer
  • Others
Applications
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Others
Companies covered
  • Illumina
  • BGI Genomics Co.,Ltd.
  • Agilent Technologies
  • Macrogen
  • Pacific Biosciences
  • Abbott
  • QIAGEN
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific, Inc.
  • Applied DNA Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Cancer Diagnostics Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Breast Cancer
  5. 1.2.3 Blood Cancer
  6. 1.2.4 Lung Cancer
  7. 1.2.5 Colorectal Cancer
  8. 1.2.6 Ovarian Cancer
  9. 1.2.7 Others
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Cancer Diagnostics Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Hospitals
  13. 1.3.3 Ambulatory Surgical Centers
  14. 1.3.4 Diagnostic Laboratories
  15. 1.3.5 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Cancer Diagnostics Service Growth Trends by Region
  18. 1.5.1 Global Cancer Diagnostics Service Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Cancer Diagnostics Service Market Size by Region (2021-2026)
  20. 1.5.3 Cancer Diagnostics Service Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Cancer Diagnostics Service Market Dynamics
  1. 2.1 Cancer Diagnostics Service Industry Trends
  2. 2.2 Cancer Diagnostics Service Industry Drivers
  3. 2.3 Cancer Diagnostics Service Industry Opportunities and Challenges
  4. 2.4 Cancer Diagnostics Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Cancer Diagnostics Service Revenue by Company (2021-2026)
  2. 3.2 Global Cancer Diagnostics Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Cancer Diagnostics Service Key Company Head office and Area Served
  4. 3.4 Global Cancer Diagnostics Service Company, Product Type & Application
  5. 3.5 Global Cancer Diagnostics Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Cancer Diagnostics Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Cancer Diagnostics Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Cancer Diagnostics Service Tier 1, Tier 2, and Tier 3
4 Cancer Diagnostics Service Market by Type
  1. 4.1 Global Cancer Diagnostics Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Cancer Diagnostics Service Market Size by Type (2021-2032)
  3. 4.3 Global Cancer Diagnostics Service Market Size Share by Type (2021-2032)
5 Cancer Diagnostics Service Market by Application
  1. 5.1 Global Cancer Diagnostics Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Cancer Diagnostics Service Market Size by Application (2021-2032)
  3. 5.3 Global Cancer Diagnostics Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Illumina
  2. 6.1.1 Illumina Company Information
  3. 6.1.2 Illumina Business Overview
  4. 6.1.3 Illumina Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Illumina Cancer Diagnostics Service Product Portfolio
  6. 6.1.5 Illumina Recent Developments
  7. 6.2 BGI Genomics Co.,Ltd.
  8. 6.2.1 BGI Genomics Co.,Ltd. Company Information
  9. 6.2.2 BGI Genomics Co.,Ltd. Business Overview
  10. 6.2.3 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product Portfolio
  12. 6.2.5 BGI Genomics Co.,Ltd. Recent Developments
  13. 6.3 Agilent Technologies
  14. 6.3.1 Agilent Technologies Company Information
  15. 6.3.2 Agilent Technologies Business Overview
  16. 6.3.3 Agilent Technologies Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Agilent Technologies Cancer Diagnostics Service Product Portfolio
  18. 6.3.5 Agilent Technologies Recent Developments
  19. 6.4 Macrogen
  20. 6.4.1 Macrogen Company Information
  21. 6.4.2 Macrogen Business Overview
  22. 6.4.3 Macrogen Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Macrogen Cancer Diagnostics Service Product Portfolio
  24. 6.4.5 Macrogen Recent Developments
  25. 6.5 Pacific Biosciences
  26. 6.5.1 Pacific Biosciences Company Information
  27. 6.5.2 Pacific Biosciences Business Overview
  28. 6.5.3 Pacific Biosciences Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Pacific Biosciences Cancer Diagnostics Service Product Portfolio
  30. 6.5.5 Pacific Biosciences Recent Developments
  31. 6.6 Abbott
  32. 6.6.1 Abbott Company Information
  33. 6.6.2 Abbott Business Overview
  34. 6.6.3 Abbott Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Abbott Cancer Diagnostics Service Product Portfolio
  36. 6.6.5 Abbott Recent Developments
  37. 6.7 QIAGEN
  38. 6.7.1 QIAGEN Company Information
  39. 6.7.2 QIAGEN Business Overview
  40. 6.7.3 QIAGEN Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 QIAGEN Cancer Diagnostics Service Product Portfolio
  42. 6.7.5 QIAGEN Recent Developments
  43. 6.8 Siemens Healthcare GmbH
  44. 6.8.1 Siemens Healthcare GmbH Company Information
  45. 6.8.2 Siemens Healthcare GmbH Business Overview
  46. 6.8.3 Siemens Healthcare GmbH Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Siemens Healthcare GmbH Cancer Diagnostics Service Product Portfolio
  48. 6.8.5 Siemens Healthcare GmbH Recent Developments
  49. 6.9 Thermo Fisher Scientific, Inc.
  50. 6.9.1 Thermo Fisher Scientific, Inc. Company Information
  51. 6.9.2 Thermo Fisher Scientific, Inc. Business Overview
  52. 6.9.3 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product Portfolio
  54. 6.9.5 Thermo Fisher Scientific, Inc. Recent Developments
  55. 6.10 Applied DNA Sciences
  56. 6.10.1 Applied DNA Sciences Company Information
  57. 6.10.2 Applied DNA Sciences Business Overview
  58. 6.10.3 Applied DNA Sciences Cancer Diagnostics Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Applied DNA Sciences Cancer Diagnostics Service Product Portfolio
  60. 6.10.5 Applied DNA Sciences Recent Developments
7 North America
  1. 7.1 North America Cancer Diagnostics Service Market Size (2021-2032)
  2. 7.2 North America Cancer Diagnostics Service Market Size by Type
  3. 7.2.1 North America Cancer Diagnostics Service Market Size by Type (2021-2026)
  4. 7.2.2 North America Cancer Diagnostics Service Market Size by Type (2027-2032)
  5. 7.2.3 North America Cancer Diagnostics Service Market Share by Type (2021-2032)
  6. 7.3 North America Cancer Diagnostics Service Market Size by Application
  7. 7.3.1 North America Cancer Diagnostics Service Market Size by Application (2021-2026)
  8. 7.3.2 North America Cancer Diagnostics Service Market Size by Application (2027-2032)
  9. 7.3.3 North America Cancer Diagnostics Service Market Share by Application (2021-2032)
  10. 7.4 North America Cancer Diagnostics Service Market Size by Country
  11. 7.4.1 North America Cancer Diagnostics Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Cancer Diagnostics Service Market Size by Country (2021-2026)
  13. 7.4.3 North America Cancer Diagnostics Service Market Size by Country (2027-2032)
  14. 7.4.4 North America Cancer Diagnostics Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Cancer Diagnostics Service Market Size (2021-2032)
  2. 8.2 Europe Cancer Diagnostics Service Market Size by Type
  3. 8.2.1 Europe Cancer Diagnostics Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe Cancer Diagnostics Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe Cancer Diagnostics Service Market Share by Type (2021-2032)
  6. 8.3 Europe Cancer Diagnostics Service Market Size by Application
  7. 8.3.1 Europe Cancer Diagnostics Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe Cancer Diagnostics Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe Cancer Diagnostics Service Market Share by Application (2021-2032)
  10. 8.4 Europe Cancer Diagnostics Service Market Size by Country
  11. 8.4.1 Europe Cancer Diagnostics Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Cancer Diagnostics Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe Cancer Diagnostics Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe Cancer Diagnostics Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Cancer Diagnostics Service Market Size (2021-2032)
  2. 9.2 China Cancer Diagnostics Service Market Size by Type
  3. 9.2.1 China Cancer Diagnostics Service Market Size by Type (2021-2026)
  4. 9.2.2 China Cancer Diagnostics Service Market Size by Type (2027-2032)
  5. 9.2.3 China Cancer Diagnostics Service Market Share by Type (2021-2032)
  6. 9.3 China Cancer Diagnostics Service Market Size by Application
  7. 9.3.1 China Cancer Diagnostics Service Market Size by Application (2021-2026)
  8. 9.3.2 China Cancer Diagnostics Service Market Size by Application (2027-2032)
  9. 9.3.3 China Cancer Diagnostics Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Cancer Diagnostics Service Market Size (2021-2032)
  2. 10.2 Asia Cancer Diagnostics Service Market Size by Type
  3. 10.2.1 Asia Cancer Diagnostics Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia Cancer Diagnostics Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia Cancer Diagnostics Service Market Share by Type (2021-2032)
  6. 10.3 Asia Cancer Diagnostics Service Market Size by Application
  7. 10.3.1 Asia Cancer Diagnostics Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia Cancer Diagnostics Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia Cancer Diagnostics Service Market Share by Application (2021-2032)
  10. 10.4 Asia Cancer Diagnostics Service Market Size by Country
  11. 10.4.1 Asia Cancer Diagnostics Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Cancer Diagnostics Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia Cancer Diagnostics Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia Cancer Diagnostics Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Cancer Diagnostics Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Cancer Diagnostics Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Cancer Diagnostics Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Cancer Diagnostics Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Cancer Diagnostics Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Cancer Diagnostics Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Cancer Diagnostics Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Cancer Diagnostics Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Cancer Diagnostics Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Cancer Diagnostics Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Cancer Diagnostics Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Cancer Diagnostics Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Cancer Diagnostics Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Cancer Diagnostics Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst